INAB INAB
Company Profile ↓Company Overview
INAB (INAB) is a publicly traded company listed on with a market capitalization of $9.67M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.10.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -52.69% |
| 6 Months: | -50.31% |
| 3 Months: | -38.96% |
| 1 Month: | -28.86% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)25.77 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 61.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | - | -2.87M | -1.68M | -2.36M | -3.05M | -3.39M | -6.14M | -7.18M | -7.40M | -7.53M | -7.71M | -7.17M | -8.56M | -8.63M | -7.09M | -5.55M | -5.09M | -3.85M | -5.09M |
| Net Income | -1.69M | -2.87M | -1.68M | -2.36M | -3.05M | -3.39M | -6.14M | -7.18M | -7.40M | -7.53M | -7.71M | -7.17M | -8.56M | -8.63M | -7.09M | -5.55M | -5.09M | -3.85M | -5.09M |
| Diluted EPS | - | - | - | - | -1.00 | -0.25 | -0.33 | -0.38 | -0.34 | -0.30 | -0.27 | -0.23 | -0.20 | -5.51 | -4.49 | -2.16 | -1.24 | -0.85 | -0.26 |
| R&D Expense | - | 1.78M | 1.06M | 1.25M | 2.06M | 1.35M | 2.38M | 3.50M | 4.25M | 4.38M | 4.13M | 3.79M | 4.90M | 5.16M | 3.31M | 2.97M | 2.49M | 2.10M | 2.61M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Income | -8.56M | -14.65M | -28.52M | -30.01M | -30.44M | -19.44M |
| Net Income | -8.56M | -14.65M | -28.52M | -30.01M | -30.44M | -19.44M |
| Diluted EPS | - | -1.47 | -1.36 | -1.00 | -17.05 | -4.44 |
| R&D Expense | 5.38M | 7.35M | 14.06M | 16.83M | 16.96M | 10.21M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 20.91M | - | 33.04M | 33.71M | 20.94M | 32.28M |
| Current Assets | - | - | - | 22.23M | 24.62M | 12.58M | 27.88M |
| Cash & Equivalents | - | - | - | 18.18M | 21.28M | 11.12M | 27.09M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - |
| Total Liabilities | - | 2.59M | - | 10.31M | 8.77M | 6.47M | 4.72M |
| Current Liabilities | - | 2.57M | - | 5.82M | 5.39M | 3.08M | 3.16M |
| Long Term Debt | - | - | - | - | - | - | - |
| Total Debt | - | - | - | 5.87M | 4.89M | 5.03M | 2.78M |
| Total Equity | -9.24M | -16.58M | - | 22.73M | 24.94M | 14.48M | 27.56M |
| Shares Outstanding | - | - | - | 818.17K | 1.44M | 2.42M | 9.77M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.13M | -13.51M | -24.12M | -23.34M | -24.15M | -12.71M |
| Investing Cash Flow | 0 | -309.00K | -3.71M | -600.00K | -187.00K | 0 |
| Financing Cash Flow | 24.52M | 32.95M | 8.99M | 27.04M | 14.18M | 28.64M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | 51.6% | - | -125.5% | -120.3% | -210.2% | -70.5% |
| ROCE % | -46.7% | - | -104.8% | -106.0% | -170.4% | -66.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for INAB
IN8bio (INAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNV0laQm9kNzlPem9NcVdzRkVDbm9BRkZMS2hfcVZNSEd6OThfa2xZdGJtdUJUWjZ1dThoQWxDVGc3T0lBZW1JX3Jta3c1WFotQnZKZ2JNOGxnT1ByZTZ2MzB0Yk5uRFF2Yk83NUh6RUpnRlZ3Y29ZRFFWMGh0c01UbzNaRTAtLUZEX2ZiaU…
Enterprise value to EBIT forward of IN8bio, Inc. – NASDAQ:INAB - TradingView
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOSEJEZWZpR3pLTVdVY3ZWRTg2SHgtQWpYU1VNOEhYQ0NCYWY1eHREaXJWSzltX3pLQklIWkpPRG1IQ0stS2RQckxYempSMHdjZEtfR1V2Q0xzUC1hekRhLUdTYVdvNXJqQVJuWTNqUHFtYV9qejlIU2hNenUwNWRKQ2NxeWs3cmFUcXdyX2…
Should I buy IN8bio (INAB) - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1tbjJvemJsQURFOUdzMmVKbkxsdDNGMmJJUTZEN2syNGVuTkRBa1FfMTRvb1AxR2ptYV82Sk9ldFdPYy04T3A1akNjZUVGSmJzS0JTUGw3X250bjV4VVkwV3U0cmIxT2tMWmpzTQ?oc=5" target="_blank">Should I buy IN8bio (…
INAB Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5jdHRYZmpGWC1PMkhGWkJmNUFqSmJrci0wSmo4ZURweE01clpqU0lteVhMdjNmTnMwZF9ScVlBSVd4SkdDN1RHbmpBUzVNcTJLa1NoeWM3cnRNY0JuODIxcE5IMlV5eW5oNG10N05rNHNyMFUtS3J4V21n?oc=5" target="_blank">INA…
INAB|IN8BIO, Inc.|Price:1.035|Chg%:-0.040 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1VbllteGd1SEFHa3lMWnUwb0NuYUdqUUZQUHppNTlIVVl5VU9hMzhpc1N0NHcxajVKOU9OREp6ZDZoU3lyWVA4c3JjMjk1eXdTR01BYVpoMEVWM3Nzc0dUQnlvTE9zZ0xVQlBnNHpB?oc=5" target="_blank">INAB|IN8BIO, Inc.|P…
IN8bio Inc. (INAB) Holds Steady Near Key Support, Awaiting Catalyst - On Balance Volume - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPRURNQVF5emdpdEdSWGdfblQ5UlRWekRRN3VPMjV0NndLb0VxUXJLb0xjSW9FdkRfMzZBMHVWZGZxcFlCcXhYUGVNTUJxbHd0dEpGQ3hPQi10TVU0OUtjRE1oYU1MaEFLczREOEtiaU5hcDlsaTlHUWtEZmNsOE9Ic0hrb2JpalUwc012Mj…
INAB — Frequently Asked Questions
What is the current share price of INAB?
As of 2026-08-05 17:25 PDT, INAB trades at $0.99 on NASDAQ/NYSE. Its 52-week range is $0.96 to $2.59.
What is the market capitalisation of INAB?
INAB has a market capitalisation of $9.67M on NASDAQ/NYSE.
What is the P/E ratio of INAB?
INAB trades at a trailing price-to-earnings (P/E) ratio of -0.22. Its price-to-book (P/B) ratio is 0.35.
What is the return on equity (ROE) of INAB?
INAB has a return on equity (ROE) of -70.54%. Its return on capital employed (ROCE) is -66.76%.
Is INAB a good stock to buy?
This page provides a data-driven analysis of INAB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.